<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thanatophoric <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (TD) is a lethal <z:hpo ids='HP_0003510'>dwarfism</z:hpo> condition due to missense mutations in the fibroblast growth factor receptor 3 (FGFR3) gene </plain></SENT>
<SENT sid="1" pm="."><plain>Examination of TD patients reveals mainly the involvement of the skeletal system and the brain, but also renal and cardiovascular anomalies have been described </plain></SENT>
<SENT sid="2" pm="."><plain>We report the prenatal detection of TD type 1 (TD1) associated with bilateral <z:hpo ids='HP_0000800'>cystic renal dysplasia</z:hpo> (CRD) Potter's type II, in which the molecular analysis reveals the typical Arg248Cys substitution in the FGFR3 gene </plain></SENT>
<SENT sid="3" pm="."><plain>CRD has not been previously described in TD or other conditions due to FGFR3 mutations, but occurs in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> (due to FGFR2 mutations) </plain></SENT>
<SENT sid="4" pm="."><plain>The possible involvement of renal developmental defect in FGFR3 mutations is discussed </plain></SENT>
</text></document>